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Foxp3þ Cells Control Th2 Responses in a Murine
Model of Atopic Dermatitis
Nanna Fyhrquist1, Sari Lehtima¨ki1, Katharina Lahl2, Terhi Savinko1, Anna-Mari Lappetela¨inen1,
Tim Sparwasser3, Henrik Wolff4, Antti Lauerma5,6,7 and Harri Alenius1
The role of Foxp3þ regulatory T (Treg) cells in atopic dermatitis (AD) is still unclear. In a murine AD model, the
number of Foxp3þ cells increased in the allergen-exposed skin area and in the secondary lymphoid organs.
Both Foxp3þ and Foxp3 IL-10þ T cells accumulated at the site of allergen exposure, and CD103þ effector/
memory Foxp3þ Treg cells expanded gradually in the lymph nodes throughout the sensitization protocol. The
depletion of Foxp3þ Treg cells led to significantly exacerbated skin inflammation, including increased
recruitment of inflammatory cells and expression of T helper type 2 cytokines, as well as elevated serum IgE
levels. The effect of depleting Treg cells during epicutaneous sensitization was mirrored off by a stronger
inflammatory response also in the lungs following airway challenge. Thus, Treg cells have an important role in
controlling AD-like inflammation and the transfer of allergic skin inflammation to the lungs.
Journal of Investigative Dermatology (2012) 132, 1672–1680; doi:10.1038/jid.2012.40; published online 8 March 2012
INTRODUCTION
Atopic dermatitis (AD) is a chronic inflammatory skin disease
manifested by dry and itchy skin, skin lesions with increased
numbers of T cells, eosinophils and mast cells, and elevated
serum IgE levels in 80% of the patients. The life-time
prevalence of AD has increased during the past decades,
reaching 17% among school-aged children in some Western
societies (Boguniewicz and Leung, 2010). Being the first step
in the so-called atopic march, AD patients often develop food
allergy, allergic rhinitis, or asthma later in life (Spergel, 2010).
Regulatory T (Treg) cells control immune homeostasis and
balance immune responses during inflammation. Treg cells
suppress immune responses by interacting with effector T (Teff)
cells or antigen-presenting cells (APC; Miyara and Sakaguchi,
2007; Vignali et al., 2008), and their regulatory role in T helper
type 2 (Th2) responses has been well established. Immune dys-
regulation, polyendocrinopathy, enteropathy, X-linked patients
with a loss-of-function mutation in the Foxp3 gene suffer from
food allergies, eczema, elevated IgE levels, and eosinophilia
(Chatila et al., 2000; Bennett et al., 2001). In mice, the lack of
Foxp3 leads to elevated serum IgE levels, eosinophilia, and
increased production of Th2 cytokines (Lin et al., 2005). Foxp3
controls signal transducer and activator of transcription (STAT6)-
dependent Th2 polarization (Lin et al., 2005) and interacts physi-
cally with GATA-3, most likely interfering with GATA3-depen-
dent transcription of IL-4, IL-5, and IL-13 (Dardalhon et al., 2008).
The role of Treg cells in AD is unclear. Treg cells can be
divided into natural Foxp3þ Treg cells (nTreg) and either
Foxp3þ or Foxp3 induced Treg cells (iTreg), including
Foxp3 IL-10þ Tr1 and Foxp3TGFbþ Th3 cells (Belkaid,
2007; Vignali et al., 2008). Some studies have observed
increased numbers of peripheral blood Foxp3þ Treg cells in
AD patients (Ou et al., 2004; Reefer et al., 2008; Ito et al., 2009),
whereas others have not (Szegedi et al., 2009). Instead, in the
latter study, the number of Tr1 cells was increased in the blood
in AD patients. In the skin, in acute and chronic AD lesions,
both the presence and absence of Foxp3þ cells have been
reported, as well as the accumulation of Tr1 cells (Verhagen
et al., 2006; Schnopp et al., 2007; Szegedi et al., 2009). Thus,
the role of Treg cells in AD needs to be further clarified.
To pin down the role of Foxp3þ Treg cells in AD, we
analyzed Treg cells and studied the effect of depleting Foxp3þ
Treg cells in the AD experimental mouse model. Our results
show that Foxp3þ Treg cells are essential regulators of Th2-
type inflammatory responses in the skin, and the effect of Treg
cell depletion during skin sensitization transfers to the lung.
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RESULTS
Topical ovalbumin (OVA) sensitization increased cellular
infiltration and the Th2 inflammatory response
Wild-type (WT) mice were sensitized as described in
Materials and Methods and Figure 1a. Compared with
phosphate-buffered saline (PBS)-treated mice, OVA-treated
mice had significantly thickened skin with increased numbers
of infiltrated eosinophils, T cells, and neutrophils (Figure 1b).
The expression of IL-4, IL-13, and IL-10 mRNA (Figure 1c)
and IL-10 protein (Supplementary Figure S1c online) in the
skin was significantly increased in the OVA group, whereas
IFN-g remained low in both groups (Figure 1c). Serum levels
of total and OVA-specific IgE were significantly elevated,
whereas OVA-specific IgG2a remained low (Figure 1d).
Foxp3þ Treg cells accumulated in the OVA-treated skin
The published data concerning the engagement of Foxp3þ
cells in AD has been controversial (Verhagen et al., 2006;
Schnopp et al., 2007; Szegedi et al., 2009). In this study,
Foxp3þ cells clearly accumulated in the skin in the OVA-
treated mice, but not in the PBS-treated controls (Figure 1e).
Yet, the ratio of Foxp3þCD3þ to Foxp3CD3þ cells
remained the same in the skin (Figure 1f) and in the draining
LNs (Figure 1g) in both groups. Moreover, OVA treatment
resulted in the accumulation of Foxp3 and Foxp3þ IL-
10þ -expressing cells in the skin (Supplementary Figure S1a
online). Finally, the ratio of CD103-expressing effector/
memory-type Treg cells increased steadily in the draining
lymph nodes (dLNs) throughout the AD protocol, starting at
15% at the beginning of the protocol and reaching 25% at the
end of the protocol. In the skin, most Foxp3þ Treg cells
expressed CD103, with slightly higher percentages of
CD103þ Tregs after OVA treatment (Figure 1h).
Treg cells from OVA-treated mice were less suppressive than
Treg cells from PBS-treated mice
The IL-4–STAT6 pathway interferes with the generation of
TGF-b-induced Foxp3þ Treg cells, as well as with the
suppressive function of nTreg cells (Mantel et al., 2007;
Dardalhon et al., 2008; Hadjur et al., 2009). The OVA-
treated mice underwent a strong Th2 shift, producing
increased levels of Th2 cytokines in the OVA-exposed tissues
(Figure 1c) and strongly elevated levels of IgE in the
serum (Figure 1d). The Th2 shift was also evident ex vivo in
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Figure 1. The AD model. (a) Topical ovalbumin (OVA) treatment led to (b) increased leukocyte recruitment and (c) elevated mRNA levels of IL-4, IL-13, and
IL-10 in the skin, as well as (d) increased IgE serum levels in OVA-sensitized mice (OVA), compared with the control group phosphate-buffered saline
(PBS). (e) Foxp3þ cell numbers in the skin increased in the OVA mice (bar¼ 50mm; in the insets bar¼ 20 mm), (f) but the Foxp3þ :Foxp3 T-cell ratio
remained similar in the PBS and OVA groups. (g) Foxp3þ /Foxp3 ratios in the dLNs were constant throughout the experiment (D0, 7, 21, 26¼ analysis on
days 0, 7, 21 and 26), (h) but the share of CD103þ Foxp3þ cells increased toward the end of the protocol. The percentage of CD103þ Foxp3þ cells
increased slightly in the skin after OVA exposure, n¼ 5–8. *Po0.05, **Po0.01, ***Po0.001; bars represent meanþ SEM. dLN, draining lymph node;
HPF, high-power field; RU, relative units; Treg, regulatory T cells.
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a-CD3-stimulated LN cells (Figure 2a). To study the possible
effect of the Th2 shift on the suppressive capacity of Foxp3þ
Treg cells, sorted CD4þ Foxp3 cells from the dLNs of
OVA-treated mice were cocultured with CD4þ Foxp3þ
T cells from either PBS- or OVA-treated mice. As shown in
Figure 2b, Treg cells from the OVA-treated mice had reduced
capacity to suppress the proliferation of the same responder
T cells.
Diphtheria toxin (DT) treatment depleted most of the Foxp3þ
cells
To assess the role of Treg cells in OVA-induced skin
inflammation, mice were administered DT to transiently
deplete Treg cells in DEREG mice (Figure 3a). The DT
treatment resulted in significantly downregulated Foxp3 both
at the mRNA and protein levels at the end of the AD protocol
(Figure 3b and c). Flow cytometric analyses of dLN cells
further confirmed the greatly reduced expression of Foxp3
(Figure 3d).
Depletion of Foxp3þ cells significantly augmented the
inflammatory response in OVA-sensitized mice
The AD model includes mild skin injury induced by tape
stripping before applying OVA. The disruption of the skin
barrier facilitates the penetration of the allergen through the
epidermal layers, and is indispensable for the induction of
OVA sensitization in the mice. The repeated tape stripping
induced a modest skin inflammation in the WT PBS-treated
irritation control mice compared with naive WT mice,
including the recruitment of a small amount of CD3þ cells
to the skin. Yet, these cells did not produce notable amounts
of IL-4 or IL-13 (Figure 4a–c). Similar to naive WT mice, there
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Figure 2. Th2 shift and Treg suppressive capacity in OVA sensitized mice. (a) dLNs from PBS- and OVA-treated mice were stimulated ex vivo with a-CD3,
followed by measurement of Th2-type cytokines, n¼ 4. (b) Treg cells from the OVA-treated mice had reduced capacity to suppress the proliferation of the
responder T cells, n¼ 3. *Po0.05, **Po0.01, ***Po0.001; bars represent meanþ SEM. CPM, counts per minute; dLN, draining lymph node; OVA, ovalbumin;
PBS, phosphate-buffered saline; Th2, T helper type 2; Treg, regulatory T cells.
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were no signs of skin inflammation in the DT-treated naive
DEREG mice (Figure 4a). However, in the DT-treated DEREG
PBS-treated irritation controls, there was a remarkable influx
of CD3þ T cells and expression of some inflammatory
mediators at the site of tape stripping (Figure 4a–c). Tape
stripping combined with OVA exposure resulted in signifi-
cantly increased recruitment of inflammatory cells to the skin,
increased local expression of Th2-type cytokines, and
elevated levels of total and OVA-specific IgE in the serum
in WT mice (Figure 4). In the OVA DEREG mice, these
parameters were further increased compared with WT mice
(Figure 4, Supplementary Figures S1 and S2 online). In the
dLNs, the depletion of Treg cells led to significantly elevated
numbers of OVA-specific IL-13-producing T cells, but
marginal numbers of OVA-specific IFN-g-expressing T cells
(Supplementary Figure S3 online).
To assess the phenotype of the remaining/regenerated
subsets of Foxp3þ and Foxp3 regulatory T cells after the
depletion of Foxp3þ T cells in the DEREG mice, LN cells
were stained for PD-1 and Helios. PD-1 is expressed both by
nTreg and iTreg cells, but at a higher level by iTreg cells, and
is essential for the conversion of naive T cells into iTreg cells
(Haribhai et al., 2011). Helios, in turn, is a marker for nTreg
cells (Thornton et al., 2010). In the DEREG mice, the frequency
of PD-1þ Foxp3þ and PD-1þ Foxp3 cells was significantly
higher, and the percentage of Heliosþ Foxp3þ T cells slightly
lower (Supplementary Figure S4 online) than in the WT mice.
T cells and dendritic cells proliferated and were activated in the
absence of Foxp3þ cells
Treg cells control inflammation by suppressing Teff cells
directly or via dendritic cells (DCs; Tang and Bluestone,
2008). The depletion of Foxp3þ cells led to significantly
increased numbers and proliferation rates of CD3þCD4þ
and CD3þCD8þ T cells, as well as CD11cþCD3 DCs in
the dLNs of OVA-treated mice (Figure 5a and b). Moreover, a
larger part of the T-cell and DC populations expressed
activation marker CD69 (Figure 5c) and costimulatory
molecules CD80 and CD86 (Figure 5d), respectively. CD80
and CD86 were also elevated at the mRNA level in the skin in
the DEREG mice (Figure 5e). Finally, there was a clear
accumulation of CD11bhiCD11cþ DCs (Hammad et al., 2009)
and skin-derived EpCamþ DCs in the dLN in the Treg-depleted
mice (Figure 5f and Supplementary Figure S5 online).
Depletion of Treg cells during epicutaneous sensitization
modulated the lung inflammation after airway challenge
More than 50% of AD patients develop food allergy, allergic
rhinitis, or asthma by 3 years of age (Boguniewicz and Leung,
2010), suggesting a connection between skin sensitization
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Figure 4. The effect of Treg cell depletion on AD-like skin inflammation. (a) Hematoxylin–eosin (H&E) staining of skin samples from wild-type (WT) mice (left
panels) and DEREG mice (right panels). Bar¼100 mm, in the insets bar¼ 20 mm. (b) Inflammatory cell counts, (c) inflammatory cytokine mRNA in the skin, and
(d) OVA-specific IgE and IgG2a serum levels were elevated in the Foxp3þ -depleted, OVA-treated mice, n¼5–8. *Po0.05, **Po0.01, ***Po 0.001; bars
represent meanþ SEM.
www.jidonline.org 1675
N Fyhrquist et al.
Foxp3þ Cells in AD
and subsequent allergy. The skin–lung association has also
been demonstrated in a mouse model (Lehto et al., 2005). To
examine the effects of Treg cell depletion during skin
sensitization on subsequent lung inflammation, mice were
subjected to airway challenge 5 days after the end of the AD
protocol, and Treg cells were depleted during the second
sensitization week (Figure 6a). The lack of Treg cells during
skin sensitization led to exacerbated lung inflammation after
intranasal OVA, including increased cellular infiltration
(Figure 6b), upregulated IL-4 expression (Figure 6c), and
increased numbers of eosinophils and CD4þ T cells in the
bronchoalveolar lavage fluid (BALF; Figure 6d). Yet, the
production of mucus and expression of IL-13 were not
affected by the lack of Treg cells (Figure 6c and data not
shown). By the time of readout, the Foxp3þ to Foxp3 T-
cell balance had been restored in the lymph nodes (LN), but
in the BALF Foxp3þ cells were outnumbered by Teff (Figure 6e).
DISCUSSION
Although the importance and function of Treg cells in the
field of allergy have been under intensive investigation, the
role of Treg cells in AD is still not clear. We explored Treg
cells in a murine model of AD, where an allergic
inflammatory response develops in the skin after recurrent
OVA applications through injured skin. The inflammatory
response in the model closely resembles the hallmarks of AD,
including increased infiltration of lymphocytes and eosino-
phils, production of Th2 cytokines, and elevation of serum
IgE levels. The number of Foxp3þ cells increased both in the
dLNs and in the skin in the OVA-treated mice compared with
the PBS-treated mice, but the Treg/Teff ratio was tightly
maintained throughout the exposure protocol. OVA treat-
ment also significantly increased the numbers of both
Foxp3þ and Foxp3 IL-10-producing T cells, indicating
the engagement of Tr1 cells. Furthermore, the phenotype of
Foxp3þ Treg cells changed over time, with a gradually
increasing share of CD103þ Treg cells toward the end of the
sensitization protocol. CD103 is a surface marker for
memory/effector Treg cells, and an important molecule for
the retention of Treg cells at the site of inflammation (Huehn
et al., 2004; Siegmund et al., 2005; Suffia et al., 2005).
Expectedly, the great majority of skin-infiltrated Treg cells
was CD103þ .
Several lines of evidence indicate that the function of
Foxp3þ Treg cells is altered in patients with allergies. For
example, Th2 responses are less effectively inhibited in
atopic individuals (Bellinghausen et al., 2003; Grindebacke
et al., 2004; Ling et al., 2004), and key constituents of Th2-
type signaling pathways, including IL-4, STAT6, and GATA3,
interfere with the generation of Treg cells and the suppressive
capacity of established Treg cells (Mantel et al., 2007;
Dardalhon et al., 2008; Hadjur et al., 2009). We show that
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the strong Th2 shift that occurs in the Balb/c mice upon OVA
sensitization is associated with impaired suppressive capacity
of Foxp3þ Treg cells. AD is associated with a Th2-polarizing
genetic background (Brown and McLean, 2009), and one
might speculate that the disease may develop upon systemic
Th2 polarization with consequences for Treg functions.
Nevertheless, we show that also potentially defective
Foxp3þ Treg cells have a crucial role in controlling AD-like
skin inflammation. Depleting naive DEREG mice of their Treg
cell compartment had no effect on the skin, proving that the
exaggerated skin inflammation in the DEREG mice is likely
not a consequence of the sole deletion of Treg cells. Tape
stripping alone induced modest skin inflammation in the PBS-
treated irritation WT controls, and, not surprisingly, a much
stronger response in the DT-treated DEREG mice. The
purpose of the tape stripping is to mimic the impaired skin
barrier function that occurs in AD patients (Marenholz et al.,
2006; Palmer et al., 2006; Kim et al., 2008) and to facilitate
the penetration of the allergen through the skin. Tape
stripping combined with OVA exposure further exacerbated
the inflammatory response, resulting in significantly in-
creased cellular infiltration, activation of Th2 cells, and
highly elevated production of OVA-specific IgE. All these
inflammatory parameters increased substantially after the
depletion of Treg cells in the OVA-treated DEREG mice.
Together, the results show that Foxp3þ Treg cells are
essential in controlling both skin injury–induced inflamma-
tion and allergen-specific immune responses, both of which
are important components of AD-associated pathology.
DT treatment resulted in extensively reduced numbers of
Foxp3þ Treg cells in the DEREG mice. Nevertheless, the
expression of IL-10 was significantly elevated in the DEREG
mice, indicating Foxp3þ Treg cell–independent IL-10
production in the skin, which is in line with previous AD
studies where the general view is that Foxp3þ Treg cells are
not the main IL-10 producers (Caproni et al., 2006; Schlotter
et al., 2011). Macrophages, DCs, and neutrophils are all
significant producers of IL-10 (Wills-Karp et al., 2001), as
well as keratinocytes and other skin cells (Vocanson et al.,
2009), and the contribution of Foxp3- Tr1 cells cannot be
excluded (Hawrylowicz and O’Garra, 2005). A larger share
of Foxp3 T cells in DEREG mice expressed PD-1 compared
with WT, which may indicate the presence of elevated
numbers of Foxp3 iTreg cells in DEREG mice after Foxp3
depletion (Haribhai et al., 2011).
Treg cells suppress inflammatory responses through
several mechanisms, such as the production of suppressive
cytokines, inhibition of Teff cell proliferation, or modulation
of DC maturation and function (Vignali et al., 2008). The
temporary deletion of Treg cells resulted in a significantly
larger share of proliferating T cells, as well as activated T cells
in the dLNs. Thus, T-cell expansion and activation are
important targets of Treg cell–mediated regulation. Further-
more, AD skin lesions are characterized by the infiltration of
CD11bhi inflammatory dendritic epidermal cells (Wollenberg
et al., 1999; Schuller et al., 2001). These cells express
costimulatory molecules CD80 and CD86, which are further
upregulated in AD (Schuller et al., 2001). Temporary deletion
of Treg cells during OVA challenge resulted in a significantly
increased share of CD11bhigh, as well as skin-derived
EpCamþ DCs in the LNs and elevated expression of CD80
and CD86 on the DCs. Clearly, the absence of Treg cells
modulated both DC activation and differentiation.
Sensitization to an allergen via the skin can lead to the
development of lung inflammation, if the same allergen is
subsequently encountered in the airways (Lehto et al., 2005).
The depletion of Treg cells during cutaneous sensitization to
OVA resulted in a stronger inflammatory response in the
OVA
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Figure 6. The effect of depleting Foxp3þ cells during epicutaneous sensitization on subsequent lung inflammation. (a) The exposure protocol and (b)
hematoxylin–eosin (H&E) staining of lung tissue. Bar¼ 100mm. (c) The expression of IL-4 and IL-13 mRNA in the lung (n¼ 5–7) and (d) the number of eosinophils
and CD4þ T cells in the BALF increased in DEREG mice. (e) The ratio of Foxp3þ cells in the LNs and Foxp3þ cell numbers in the BALF, n¼ 2–3. *Po0.05,
**Po0.01; bars represent meanþ SEM. BALF, bronchoalveolar lavage fluid; HPF, high-power field; LN, lymph node; OVA, ovalbumin; PBS, phosphate-buffered
saline; RU, relative units; WT, wild type.
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lungs after OVA airway challenge. Although Treg/Teff ratios
in the LNs had been restored, Teff cells outnumbered Treg
cells locally in the lungs, indicating divergent regulation of
the allergen-specific response.
To conclude, we show that Foxp3þ Treg cells are
essential suppressors of AD-like skin inflammation, and that
the presence of Treg cells at the time of epicutaneous protein
exposure is important for the regulation of subsequent airway
inflammation.
MATERIALS AND METHODS
Mice and experimental models
DEREG (depletion of regulatory T cells) mice (Lahl et al., 2007) in
C57/Black background were backcrossed to Balb/c mice (Scanbur,
Sollentuna, Sweden) at least five times. These mice harbor genes for
enhanced green fluorescent protein (EGFP) and DT receptor under
the control of Foxp3 promoter. Mice were genotyped and grouped
into DEREG mice and WT mice. For suppression assay and Treg
kinetics studies, C.Cg-Foxp3tm2Tch/J mice (The Jackson Laboratory,
Bar Harbor, ME) that express EGFP under the control of Foxp3
promoter were used. All the procedures concerning animals were
accepted by Social and Health Services of State Provincial Office of
Southern Finland.
In the AD model, OVA sensitization was carried out as previously
described with a few modifications (Spergel et al., 1998). Briefly, 10-
to 14-week-old female mice were anesthetized and their backs were
shaved. Skin injury was induced by repeated tape stripping, after
which 100mg of OVA in 100 ml of PBS, or PBS only, was applied on a
sterile patch and attached to the tape-stripped area with an adhesive
tape. Treatment was repeated once during the 1-week sensitization
period after which a 2-week resting period was kept before a second,
similar kind of sensitization week. The mice were killed and samples
collected 24 hours after the last treatment. DT (Calbiochem, La Jolla,
CA) was administered intraperitoneally during the second sensitiza-
tion week simultaneously with the patch treatment: 1mg during the
first and 0.5 mg during the second treatment. DT was administered
similarly in naive mice. In the asthma model, the sensitization was
carried out as in the AD model. Four days after the last patch
treatment, patches were removed, and 5 days thereafter mice were
given 50mg of OVA in 50 ml of PBS (OVA group) or 50ml PBS (PBS
group) intranasally on three consecutive days and samples were
collected 48 hours after last treatment.
Histology
Skin or lung tissue was fixed in 10% formalin and embedded in
paraffin. Multiple 4-mm-thick sections were stained with hematox-
ylin–eosin or periodic acid Schiff.
Immunohistochemistry
For immunohistochemical staining, samples obtained from ex-
posed skin were immersed in Tissue-Tek oxacalcitriol compound
(Sakura Finetek, Alphen aan den Rijn, Netherlands) and frozen on
dry ice. Frozen sections (4 mm) were fixed with cold acetone and
immunoperoxidase staining was used to detect CD3 (BD Bio-
sciences, NJ), Foxp3 (eBiosciences, San Diego, CA), or IL-10
(Abcam, Cambridge, UK). Biotin-conjugated secondary antibody
anti-rat IgG (Hþ L) was purchased from Vector Laboratories
(Servion, Switzerland).
RNA isolation and real-time quantitative PCR
Skin from the exposed area or lung tissue was homogenized in
Trisure (Bioline, London, UK). RNA was extracted according to the
manufacturer’s instructions and used as a template for cDNA
synthesis. Real-time quantitative PCR analysis was performed with
7500 Fast Real Time PCR system (Applied Biosystems, Carlsbad, CA)
using commercial primers and probes. Ribosomal 18S was used as
an endogenous control. All primers and probes were purchased from
Applied Biosystems.
Serum IgE antibodies
Total IgE levels in the serum were measured as previously described
(Savinko et al., 2005). For measurements of OVA-specific IgE and
IgG2a, the plate was coated with rat anti-mouse IgE/IgG2a mAb (BD
Biosciences, NJ). Diluted sera were allowed to bind overnight and
bound IgE/IgG2a was detected with biotinylated OVA, Streptavi-
din–HRP (BD Biosciences, NJ), and peroxidase substrate reagents
(Kirkegaard & Perry Laboratories, Gaithersburg, MD). Absorbance at
405 nm was read with an automated ELISA reader (Titertek Multi-
scan, Eflab, Turku, Finland).
Cytokine ELISAs
LN cell suspensions were stimulated with a-CD3, and cytokine
production was measured at 48 hours with commercial ELISA kits.
OptEIASet Mouse IL-5 (BD Biosciences, San Jose, CA) was used for
detection of IL-5, Mouse IL-4 ELISA Ready-SET-Go! (eBioscience,
San Diego, CA) for IL-4, and Quantikine M MURINE mouse IL-13
(R & D Systems, Minneapolis, MN) for IL-13.
Single-cell preparations and flow cytometry
Single-cell suspensions from the inflamed skin were prepared by
cutting the skin sample into small pieces, passing through a 70-mm
cell strainer, washing with PBS, and filtering again through a 40-mm
cell strainer (BD Biosciences). LN cells were isolated by crushing the
nodes and filtering through a 100-mm strainer. BALF cells were used
as such. Antibodies PE (phycoerythrin)–Cy7-conjugated anti-CD3 (BD
Biosciences), PerCP–Cy5-conjugated anti-CD4, Alexa Fluor700-con-
jugated anti-CD8, APC-conjugated CD103, PE-conjugated PD-1,
PerCP–Cy5.5-conjugated CD11b, APC-Alexa750-conjugated CD11c,
PE-conjugated EpCam, PE-conjugated CD86, and APC-conjugated
CD80 (eBiosciences) were used for surface stainings. For intracellular
stainings, cells were fixed and permeabilized with a commercial
Foxp3 staining kit (eBiosciences) according to the manufacturer’s
instructions, and the cells were stained with PE- or Alexa
Fluor700–conjugated Foxp3, APC-conjugated CD69 (eBiosciences),
AlexaFluor 647–conjugated Helios (Biolegend, San Diego, CA), or
PE-conjugated Ki-67 (BD Biosciences). For intracellular cytokine
detection, cells were stimulated with OVA (50mgml1) or Phorbol
myristate acetate (20ngml1) and Ionomycin (1mgml1) in the
presence of Brefeldin A (10mg ml1) for 4 hours, fixed and per-
meabilized with Fix and Perm kit from Caltag (CA), and stained with
PE-conjugated anti-IL-13, APC-conjugated IFN-g, or IL-10 (eBios-
ciences, CA). Samples were run with FacsCantoII (BD Biosciences)
and results analyzed with the FlowJo software (Tree Star, Ashland, OR).
Suppression assay
CD4þ cells were isolated from LN cell suspensions with the
Robosep CD4þ cell-positive selection kit (StemCell Technologies,
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Grenoble, France), and sorted into eGFPþ (BFoxp3þ ) and
eGFP (BFoxp3) fractions. CD4þ Foxp3 cells from OVA-
treated mice were seeded at 3 104 cells per well in complete
RPMI-1640 medium (Invitrogen Life Technologies, Carlsbad, CA),
and stimulated with a-CD3 (0.75 mg ml1) and a-CD28 (2.5 mg ml1)
in the presence of CD4þ Foxp3þ cells from PBS- or OVA-treated
mice at responder suppressor cell ratios as indicated. The cells were
cultured in 371C/5% CO2 for 72 hours and pulsed with 1 mCi
[3H]thymidine per well (Amersham Biosciences Europe, Freiburg,
Germany) during the last 18 hours. Incorporated radioactivity was
determined using a liquid scintillation counter (Trilux 1450
Microbeta, Wallac, Turku, Finland). Results are expressed as mean
counts per minute of triplicate wells.
Statistical analyses
Statistical analyses were performed with t-test and nonparametric
Mann–Whitney U-test using the GraphPad Prism software (GraphPad
Software, LaJolla, CA).
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